Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Serum Studies: Renal Function Tests01:24

Serum Studies: Renal Function Tests

Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.
Hormonal Regulation of Blood Pressure01:17

Hormonal Regulation of Blood Pressure

Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction while...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

N-terminal proBNP adds prognostic value to high-sensitivity cardiac troponin I in elective thoracic surgery: an observational cohort study.

BMJ open·2026
Same author

Improving the Compliance of Massive Hemorrhage Protocols Through Education Is Associated with Patient Survival.

Journal of clinical medicine·2025
Same author

Apolipoproteins in Health and Disease.

International journal of molecular sciences·2024
Same author

The Relevance of Implementing the Systematic Screening of Perioperative Myocardial Injury in Noncardiac Surgery Patients.

Journal of clinical medicine·2023
Same author

Non-invasive electromechanical assessment during atrial fibrillation identifies underlying atrial myopathy alterations with early prognostic value.

Nature communications·2023
Same author

Single Troponin Measurement to Rule Out Myocardial Infarction: JACC Review Topic of the Week.

Journal of the American College of Cardiology·2023
Same journal

Assessing neonatal and paediatric acute kidney injury: current practices and insights from the IFCC C-ETPLM International Laboratory Survey.

Clinical chemistry and laboratory medicine·2026
Same journal

A novel comprehensive non-invasive prenatal testing system for the simultaneous detection of single-gene disorders, chromosomal structural rearrangements, and aneuploidy.

Clinical chemistry and laboratory medicine·2026
Same journal

Fish-shaped erythrocytes and pincer cells co-occur in distinct hematological disorders and are associated with anemia severity.

Clinical chemistry and laboratory medicine·2026
Same journal

Artificial general intelligence and the clinical laboratory: a paradigm shift toward Lab 2.0.

Clinical chemistry and laboratory medicine·2026
Same journal

Addressing property and unit discordance in laboratory interoperability: the role of NPU as a governance layer.

Clinical chemistry and laboratory medicine·2026
Same journal

Ethical evaluation of reflex and reflective testing in conformity with ISO 15189:2022 at the value-based laboratory medicine era.

Clinical chemistry and laboratory medicine·2026
See all related articles

Related Experiment Video

Updated: Jun 28, 2026

Nitropeptide Profiling and Identification Illustrated by Angiotensin II
07:31

Nitropeptide Profiling and Identification Illustrated by Angiotensin II

Published on: June 16, 2019

Natriuretic peptide testing in emergency settings.

Jordi Ordonez-Llanos1, Javier Merce-Muntanola, Miquel Santalo-Bel

  • 1Servei de Bioquímica, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain. jordonez@santpau.cat

Clinical Chemistry and Laboratory Medicine
|November 18, 2008
PubMed
Summary
This summary is machine-generated.

B-type natriuretic peptide tests accurately diagnose heart failure in patients with acute dyspnea. This biomarker also predicts complications and reduces healthcare costs, aiding in early risk identification.

More Related Videos

Endotoxin Activity Assay for the Detection of Whole Blood Endotoxemia in Critically Ill Patients
06:28

Endotoxin Activity Assay for the Detection of Whole Blood Endotoxemia in Critically Ill Patients

Published on: June 24, 2019

Related Experiment Videos

Last Updated: Jun 28, 2026

Nitropeptide Profiling and Identification Illustrated by Angiotensin II
07:31

Nitropeptide Profiling and Identification Illustrated by Angiotensin II

Published on: June 16, 2019

Endotoxin Activity Assay for the Detection of Whole Blood Endotoxemia in Critically Ill Patients
06:28

Endotoxin Activity Assay for the Detection of Whole Blood Endotoxemia in Critically Ill Patients

Published on: June 24, 2019

Area of Science:

  • Cardiology
  • Pulmonology
  • Biomarker Research

Background:

  • Acutely dyspneic patients present diagnostic challenges due to diverse underlying causes.
  • Clinical assessment alone has limitations in accurately identifying heart failure as the cause of dyspnea.

Purpose of the Study:

  • To evaluate the diagnostic and prognostic utility of B-type natriuretic peptide testing in acutely dyspneic patients.
  • To assess the impact of natriuretic peptide testing on clinical management and healthcare costs.

Main Methods:

  • Utilized B-type natriuretic peptide testing for diagnostic accuracy assessment.
  • Analyzed prognostic value of natriuretic peptides for complications.
  • Evaluated economic impact of systematic natriuretic peptide testing.

Main Results:

  • B-type natriuretic peptide testing shows high diagnostic accuracy (85%-90%) for heart failure in dyspneic patients.
  • Negative predictive value (>90%) effectively rules out heart failure.
  • Natriuretic peptides serve as powerful prognostic markers for acute dyspnea complications, enabling early high-risk patient recognition.

Conclusions:

  • B-type natriuretic peptide testing is a valuable tool for diagnosing heart failure and identifying high-risk patients with acute dyspnea.
  • Systematic testing can reduce healthcare expenses associated with managing acute dyspnea.
  • Further research is needed to determine if natriuretic peptides can guide acute heart failure therapy.